WebMelt Pharmaceuticals was planning to go public, but the IPO has been withdrawn. Stock Price: Pending IPO price not available yet Overview Financials Statistics Profile Income Balance Sheet Cash Flow Ratios Annual Quarterly Trailing Ratios and Metrics ( Annual) Market cap in millions USD. Fiscal year is January - December. Current Millions Export Webwww.meltpharma.com Ownership Status In IPO Registration Financing Status Corporate Backed or Acquired Primary Industry Drug Discovery Other Industries Pharmaceuticals …
Phase 2 sedative and anesthesia biotech Melt Pharmaceuticals …
Web27 sep. 2024 · A high-level overview of Melt Pharmaceuticals, Inc. (MELT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Web10 okt. 2024 · Gland Pharma Limited IPO: Mainline: Nov 20, 2024 ₹1500.00 ₹1820.45 ₹1819.55 ₹1250.7 ₹6479.55 Cr: 11: Chandra Bhagat Pharma Ltd IPO: SME: Feb 14, 2024 ₹51.00: 51 ₹51.75 ₹97 ₹10.20 Cr: 12: Earum Pharmaceuticals Limited IPO: SME: Jul 04, 2024 ₹36.00 ₹36.05 ₹2.33 ₹6.65 Cr: 13: Cian Healthcare Limited IPO: SME: May 23, … chinese tallow images
Melt Pharmaceuticals (MELT) Financial Ratios and Metrics
Web4 jan. 2024 · Melt Pharmaceuticals, a Phase 2 biotech developing non-opioid, non-IV sedatives and anesthesia, withdrew its plans for an initial public offering on Wednesday. It originally filed in September 2024 with a … Web22 sep. 2024 · Melt Pharmaceuticals, Inc. – Melt Pharmaceuticals IPO 財經導航 2024年9月22日 15:21 阅读 (34) 評論 (0) 簡要信息 Melt Pharmaceuticals是一家臨床階段製藥 … Web10 mrt. 2024 · Melt Pharmaceuticals Names Veteran Executive Brad Osborne as Chief Financial Officer. by Shawn Johnson. March 10, 2024. in ... chinese tallow plant